Impact of Diabetes, Drug-Induced Liver Injury, and Sepsis on Outcomes in MAFLD-Related Acute-on-Chronic Liver Failure.
Ashish KumarAnil AroraAshok ChoudhuryVinod AroraMohamed RelaDinesh Kumar JothimaniMamun A MahtabHarshad C DevarbhaviChundamannil Eapen EapenAshish GoelCésar YaghiQin NingTao ChenJi-Dong JiaZhongping DuanSaeed S HamidAmna Subhan ButtWasim JafriAkash ShuklaSeok S TanDong J KimAnoop SarayaJinhua HuAjit SoodOmesh GoyalVandana MidhaGirish Kumar PatiAyaskanta SinghGuan Huei LeeSombat TreeprasertsukKessarin ThanapiromAmeet MandotRavikiran MaghadeCosmas Rinaldi Adithya LesmanaHasmik GhazinyanVirukalpatti G Mohan PrasadAbdul K DokmeciJose D SollanoZaigham AbbasAnanta ShresthaGeorge K K LauDiana A PayawalGamal E ShihaAjay Kumar DusejaSunil TanejaNipun VermaPadaki N RaoAnand V KulkarniFazal KarimVivek A SaraswatShahinul AlamDebashis ChowdhuryChandan Kumar KedarisettySanjiv SaigalPraveen SharmaGhulam N YattooAbraham KoshyAjay Kumar PatwaMohamed ElbasionyPravin M RathiSudhir MaharshiVishwa M DayalAshish Kumar JhaKemal Fariz KalistaRino Alvani GaniMan Fung YuenVirendra SinghVioleta A SargsyanChien H HuangSaurabh S MukewarShaojie XinRuveena Bhavani RajaramCharles PanackelSunil DadhichSanjeev SachdevaAjay KumarSanatan BeheraLubna KamaniHemamala V SaithanyamurthiBabita PrasadShiv Kumar Sarinnull nullPublished in: The American journal of gastroenterology (2024)
Almost half of MAFLD-ACLF patients die within 90 days. Diabetes and non-viral precipitants such as DILI and sepsis lead to adverse outcomes. The new MAFLD-MELD-Na and MAFLD-AARC scores provide reliable 90-day mortality predictions for MAFLD-ACLF patients.
Keyphrases